Merck And Co Inc (MRK) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Merck and Co Inc   (NYSE: MRK)

Merck And Co Inc Profitability Comparisons

Select each Category to receive further Information




MRK Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 73.54 % 70.91 % 65.43 % 46.08 %
Gross Margin (Q2 TTM) 72.97 % 71.7 % 65.99 % 46.3 %
Gross Profit Margin 5 Yr. Avg. 73.39 % 67.81 % 65.55 % 48.95 %
EBITDA Margin (Q2 MRQ) 5.42 % 21.45 % 18.99 % 20.49 %
EBITDA Margin (Q2 TTM) 19.02 % 25.15 % 21.01 % 20.13 %
EBITDA Margin 5 Yr. Avg. 31.7 % 47.09 % 31.38 % 23.41 %
Operating Margin (Q2 MRQ) 0 % 17.27 % 16.58 % 16.05 %
Operating Margin (Q2 TTM) 10.46 % 20.33 % 17.81 % 16.34 %
Operating Margin 5 Yr. Avg. 24.72 % 15.37 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q2 MRQ) -4.11 % 13.66 % 10.94 % 13.96 %
Pre-Tax Profit Margin (Q2 TTM) 8.94 % 16.7 % 12.79 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. 24.57 % 12.98 % 10.37 % 13.52 %
Net Margin (Q2 MRQ) -8.05 % 10.09 % 8.15 % 11.42 %
Net Margin (Q2 TTM) 4.76 % 13.13 % 9.94 % 10.76 %
Net Margin 5 Yr. Avg. 21.35 % 5.79 % 6.08 % 10.8 %



Business Segment Profit Margin
 
U S
  Explore U S Segment  -
Non-US
  Explore Non-US Segment  -
Corporate Non-Segment
  Explore Corporate Non-Segment Segment  -
Corporate Non-U S
  Explore Corporate Non-U S Segment  -
Corporate Non-Non-US
  Explore Corporate Non-Non-US Segment  -
Pharmaceutical
  Explore Pharmaceutical Segment  -
Animal Health
  Explore Animal Health Segment  -
United States
  Explore United States Segment  -
Europe Middle East and Africa
  Explore Europe Middle East and Africa Segment  -
China
  Explore China Segment  -
Latin America
  Explore Latin America Segment  -
Japan
  Explore Japan Segment  -
Asia Pacific other than China and Japan
  Explore Asia Pacific other than China and Japan Segment  -
Other
  Explore Other Segment  -
U S Pharmaceutical
  Explore U S Pharmaceutical Segment  -
U S Animal Health
  Explore U S Animal Health Segment  -
Non-US Pharmaceutical
  Explore Non-US Pharmaceutical Segment  -
Non-US Animal Health
  Explore Non-US Animal Health Segment  -
Keytruda Pharmaceutical
  Explore Keytruda Pharmaceutical Segment  -
Keytruda U S Pharmaceutical
  Explore Keytruda U S Pharmaceutical Segment  -
Keytruda Non-US Pharmaceutical
  Explore Keytruda Non-US Pharmaceutical Segment  -
Alliance revenue - Lynparza Pharmaceutical
  Explore Alliance revenue - Lynparza Pharmaceutical Segment  -
Alliance revenue - Lynparza U S Pharmaceutical
  Explore Alliance revenue - Lynparza U S Pharmaceutical Segment  -
Alliance revenue - Lynparza Non-US Pharmaceutical
  Explore Alliance revenue - Lynparza Non-US Pharmaceutical Segment  -
Alliance revenue - Lenvima Pharmaceutical
  Explore Alliance revenue - Lenvima Pharmaceutical Segment  -
Alliance revenue - Lenvima U S Pharmaceutical
  Explore Alliance revenue - Lenvima U S Pharmaceutical Segment  -
Alliance revenue - Lenvima Non-US Pharmaceutical
  Explore Alliance revenue - Lenvima Non-US Pharmaceutical Segment  -
Welireg Pharmaceutical
  Explore Welireg Pharmaceutical Segment  -
Welireg U S Pharmaceutical
  Explore Welireg U S Pharmaceutical Segment  -
Welireg Non-US Pharmaceutical
  Explore Welireg Non-US Pharmaceutical Segment  -
Alliance Revenue - Reblozyl Pharmaceutical
  Explore Alliance Revenue - Reblozyl Pharmaceutical Segment  -
Alliance Revenue - Reblozyl U S Pharmaceutical
  Explore Alliance Revenue - Reblozyl U S Pharmaceutical Segment  -
Alliance Revenue - Reblozyl Non-US Pharmaceutical
  Explore Alliance Revenue - Reblozyl Non-US Pharmaceutical Segment  -
Gardasil Gardasil 9 Pharmaceutical
  Explore Gardasil Gardasil 9 Pharmaceutical Segment  -
Gardasil Gardasil 9 U S Pharmaceutical
  Explore Gardasil Gardasil 9 U S Pharmaceutical Segment  -
Gardasil Gardasil 9 Non-US Pharmaceutical
  Explore Gardasil Gardasil 9 Non-US Pharmaceutical Segment  -
ProQuad M-M-R II Varivax Pharmaceutical
  Explore ProQuad M-M-R II Varivax Pharmaceutical Segment  -
ProQuad M-M-R II Varivax U S Pharmaceutical
  Explore ProQuad M-M-R II Varivax U S Pharmaceutical Segment  -
ProQuad M-M-R II Varivax Non-US Pharmaceutical
  Explore ProQuad M-M-R II Varivax Non-US Pharmaceutical Segment  -
Vaxneuvance Pharmaceutical
  Explore Vaxneuvance Pharmaceutical Segment  -
Vaxneuvance U S Pharmaceutical
  Explore Vaxneuvance U S Pharmaceutical Segment  -
Vaxneuvance Non-US Pharmaceutical
  Explore Vaxneuvance Non-US Pharmaceutical Segment  -
RotaTeq Pharmaceutical
  Explore RotaTeq Pharmaceutical Segment  -
RotaTeq U S Pharmaceutical
  Explore RotaTeq U S Pharmaceutical Segment  -
RotaTeq Non-US Pharmaceutical
  Explore RotaTeq Non-US Pharmaceutical Segment  -
Capvaxive Pharmaceutical
  Explore Capvaxive Pharmaceutical Segment  -
Capvaxive U S Pharmaceutical
  Explore Capvaxive U S Pharmaceutical Segment  -
Capvaxive Non-US Pharmaceutical
  Explore Capvaxive Non-US Pharmaceutical Segment  -
Bridion Pharmaceutical
  Explore Bridion Pharmaceutical Segment  -
Bridion U S Pharmaceutical
  Explore Bridion U S Pharmaceutical Segment  -
Bridion Non-US Pharmaceutical
  Explore Bridion Non-US Pharmaceutical Segment  -
Prevymis Pharmaceutical
  Explore Prevymis Pharmaceutical Segment  -
Prevymis U S Pharmaceutical
  Explore Prevymis U S Pharmaceutical Segment  -
Prevymis Non-US Pharmaceutical
  Explore Prevymis Non-US Pharmaceutical Segment  -
Zerbaxa Pharmaceutical
  Explore Zerbaxa Pharmaceutical Segment  -
Zerbaxa U S Pharmaceutical
  Explore Zerbaxa U S Pharmaceutical Segment  -
Zerbaxa Non-US Pharmaceutical
  Explore Zerbaxa Non-US Pharmaceutical Segment  -
Dificid Pharmaceutical
  Explore Dificid Pharmaceutical Segment  -
Dificid U S Pharmaceutical
  Explore Dificid U S Pharmaceutical Segment  -
Dificid Non-US Pharmaceutical
  Explore Dificid Non-US Pharmaceutical Segment  -
Winrevair Pharmaceutical
  Explore Winrevair Pharmaceutical Segment  -
Winrevair U S Pharmaceutical
  Explore Winrevair U S Pharmaceutical Segment  -
Winrevair Non-US Pharmaceutical
  Explore Winrevair Non-US Pharmaceutical Segment  -
Alliance revenue - Adempas Verquvo Pharmaceutical
  Explore Alliance revenue - Adempas Verquvo Pharmaceutical Segment  -
Alliance revenue - Adempas Verquvo U S Pharmaceutical
  Explore Alliance revenue - Adempas Verquvo U S Pharmaceutical Segment  -
Adempas Pharmaceutical
  Explore Adempas Pharmaceutical Segment  -
Adempas Non-US Pharmaceutical
  Explore Adempas Non-US Pharmaceutical Segment  -
Lagevrio Pharmaceutical
  Explore Lagevrio Pharmaceutical Segment  -
Lagevrio U S Pharmaceutical
  Explore Lagevrio U S Pharmaceutical Segment  -
Lagevrio Non-US Pharmaceutical
  Explore Lagevrio Non-US Pharmaceutical Segment  -
Isentress Isentress HD Pharmaceutical
  Explore Isentress Isentress HD Pharmaceutical Segment  -
Isentress Isentress HD U S Pharmaceutical
  Explore Isentress Isentress HD U S Pharmaceutical Segment  -
Isentress Isentress HD Non-US Pharmaceutical
  Explore Isentress Isentress HD Non-US Pharmaceutical Segment  -
Delstrigo Pharmaceutical
  Explore Delstrigo Pharmaceutical Segment  -
Delstrigo U S Pharmaceutical
  Explore Delstrigo U S Pharmaceutical Segment  -
Delstrigo Non-US Pharmaceutical
  Explore Delstrigo Non-US Pharmaceutical Segment  -
Januvia Pharmaceutical
  Explore Januvia Pharmaceutical Segment  -
Januvia U S Pharmaceutical
  Explore Januvia U S Pharmaceutical Segment  -
Januvia Non-US Pharmaceutical
  Explore Januvia Non-US Pharmaceutical Segment  -
Janumet Pharmaceutical
  Explore Janumet Pharmaceutical Segment  -
Janumet U S Pharmaceutical
  Explore Janumet U S Pharmaceutical Segment  -
Janumet Non-US Pharmaceutical
  Explore Janumet Non-US Pharmaceutical Segment  -
Other pharmaceutical Pharmaceutical
  Explore Other pharmaceutical Pharmaceutical Segment  -
Other pharmaceutical U S Pharmaceutical
  Explore Other pharmaceutical U S Pharmaceutical Segment  -
Other pharmaceutical Non-US Pharmaceutical
  Explore Other pharmaceutical Non-US Pharmaceutical Segment  -
Livestock Animal Health
  Explore Livestock Animal Health Segment  -
Livestock U S Animal Health
  Explore Livestock U S Animal Health Segment  -
Livestock Non-US Animal Health
  Explore Livestock Non-US Animal Health Segment  -
Companion Animal Animal Health
  Explore Companion Animal Animal Health Segment  -
Companion Animal U S Animal Health
  Explore Companion Animal U S Animal Health Segment  -
Companion Animal Non-US Animal Health
  Explore Companion Animal Non-US Animal Health Segment  -
Alliance revenue - Koselugo Pharmaceutical
  Explore Alliance revenue - Koselugo Pharmaceutical Segment  -
Total profits
  Explore Total profits Segment  -
Total profits Pharma- ceutical
  Explore Total profits Pharma- ceutical Segment  -
Total profits Animal Health
  Explore Total profits Animal Health Segment  -
Other profits
  Explore Other profits Segment  -
Keytruda Qlex Pharmaceutical
  Explore Keytruda Qlex Pharmaceutical Segment  -
Keytruda Qlex U S Pharmaceutical
  Explore Keytruda Qlex U S Pharmaceutical Segment  -
Keytruda Qlex Non-US Pharmaceutical
  Explore Keytruda Qlex Non-US Pharmaceutical Segment  -
Ohtuvayre Pharmaceutical
  Explore Ohtuvayre Pharmaceutical Segment  -
Ohtuvayre U S Pharmaceutical
  Explore Ohtuvayre U S Pharmaceutical Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q2 MRQ) 26.96 % -0.01 % 0.21 % 1.39 %
Free Cash Flow Margin (Q2 TTM) 24.13 % 17.24 % 13.85 % 9.11 %
Free Cash Flow Margin 5 Yr. Avg. - 19.28 % 14.86 % 15.58 %
Net Cash Flow Margin (Q2 MRQ) 0 % 0.02 % -0.02 % 0.13 %
Net Cash Flow Margin (Q2 TTM) -4.02 % -0.66 % 0.13 % 1.85 %
Net Cash Flow Margin 5 Yr. Avg. - 4.38 % 3.16 % 6.44 %
Effective Tax Rate (Q2 MRQ) -95.75 % 25.98 % 25.39 % 18.83 %
Effective Tax Rate (Q2 TTM) 46.7 % 21.21 % 22.93 % 19.44 %
Effective Tax Rate 5 Yr. Avg. 26.01 % 15.08 % 20.51 % 19.76 %
Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.